SCHEMBL21036264

SCHEMBL21036264

CC(C)(C)OC(=O)NC1CCN(C(=O)[C@@H]2CN(C(=O)c3ccc(OC(F)(F)F)cc3)CCN2S(=O)(=O)c2ccc3cc(OC4CCCC4)ccc3c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 4/20 0.47
MMP9 P14780 4/20 0.47
MMP13 P45452 3/20 0.47
PDE4B Q07343 4/20 0.40
PDE4D Q08499 2/20 0.40
PRKAA2 P54646 1/20 0.39
WNT3 P56703 3/20 0.38
SFRP1 Q8N474 3/20 0.38
EPHX2 P34913 5/20 0.38
NAMPT P43490 1/20 0.38
GHSR Q92847 1/20 0.37
MMP3 P08254 3/20 0.37
MMP7 P09237 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21036265 0.86 MMP1 (0.48) MMP1MMP9MMP13PDE4BPDE4D
SCHEMBL21035472 0.84 MMP1 (0.49) MMP1MMP9MMP13EPHX2NAMPT
Trifluoroacetic Acid SCHEMBL21002051 0.84 MMP1 (0.46) MMP1MMP9MMP13PDE4BPDE4D
Trifluoroacetic Acid SCHEMBL21002053 0.84 MMP1 (0.46) MMP1MMP9MMP13PDE4BPDE4D
SCHEMBL21034935 0.82 CCR4 (0.42) MMP1MMP9MMP13PRKAA2WNT3
SCHEMBL21035077 0.81 LMNA (0.39) MMP1MMP9MMP13WNT3SFRP1
SCHEMBL21035117 0.81 LMNA (0.39) MMP1MMP9MMP13WNT3SFRP1
SCHEMBL21036266 0.80 ITGB1 (0.40) WNT3SFRP1EPHX2
SCHEMBL21035343 0.80 CCR4 (0.42) MMP1MMP9MMP13PRKAA2GHSR
SCHEMBL21035497 0.79 KCNH2 (0.43) MMP1MMP9MMP13GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed